Lactate dehydrogenase levels in immune thrombocytopenia
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at a blood marker called lactate dehydrogenase (LDH) in people who have just been diagnosed with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing low platelet counts and bleeding risk. The goal is to see if LDH levels are linked to the disease, which might help doctors understand or monitor it better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with immune thrombocytopenia (ITP) and are newly diagnosed.
- You do not have any bone fractures, bone diseases, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an IV medicine called V-IMMUNE® for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if V-IMMUNE® can safely raise platelet counts in both children and adults.
This study looks at how people with immune thrombocytopenia (ITP) are treated in real life. It aims to understand which treatments work best for patients who have had ITP for up to 12 months.
This study follows people who have immune thrombocytopenia (ITP), a condition where the blood doesn't clot properly because of low platelets. By tracking patients over time, researchers hope to learn more about the disease and how it affects people.
This study follows patients who have both immune thrombocytopenia (ITP) and a recent ischemic stroke to learn more about their health over time. If you fit these criteria, joining may help doctors better understand how to care for people with these conditions.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study looks at vitamin D levels in adults with newly diagnosed immune thrombocytopenia (ITP), a condition where your immune system attacks your platelets. It aims to see if low vitamin D might be related to how the disease responds to first-line steroid treatment.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.